Literature DB >> 14651460

Venezuelan equine encephalitis.

Scott C Weaver1, Cristina Ferro, Roberto Barrera, Jorge Boshell, Juan-Carlos Navarro.   

Abstract

Venezuelan equine encephalitis virus (VEEV) remains a naturally emerging disease threat as well as a highly developed biological weapon. Recently, progress has been made in understanding the complex ecological and viral genetic mechanisms that coincide in time and space to generate outbreaks. Enzootic, equine avirulent, serotype ID VEEV strains appear to alter their serotype to IAB or IC, and their vertebrate and mosquito host range, to mediate repeated VEE emergence via mutations in the E2 envelope glycoprotein that represent convergent evolution. Adaptation to equines results in highly efficient amplification, which results in human disease. Although epizootic VEEV strains are opportunistic in their use of mosquito vectors, the most widespread outbreaks appear to involve specific adaptation to Ochlerotatus taeniorhynchus, the most common vector in many coastal areas. In contrast, enzootic VEEV strains are highly specialized and appear to utilize vectors exclusively in the Spissipes section of the Culex (Melanoconion) subgenus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14651460     DOI: 10.1146/annurev.ento.49.061802.123422

Source DB:  PubMed          Journal:  Annu Rev Entomol        ISSN: 0066-4170            Impact factor:   19.686


  159 in total

1.  Candidate vectors and rodent hosts of Venezuelan equine encephalitis virus, Chiapas, 2006-2007.

Authors:  Eleanor R Deardorff; Jose G Estrada-Franco; Jerome E Freier; Roberto Navarro-Lopez; Amelia Travassos Da Rosa; Robert B Tesh; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  The SD1 Subdomain of Venezuelan Equine Encephalitis Virus Capsid Protein Plays a Critical Role in Nucleocapsid and Particle Assembly.

Authors:  Josephine M Reynaud; Valeria Lulla; Dal Young Kim; Elena I Frolova; Ilya Frolov
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

3.  Rapid, non-invasive imaging of alphaviral brain infection: reducing animal numbers and morbidity to identify efficacy of potential vaccines and antivirals.

Authors:  Michael Patterson; Allison Poussard; Katherine Taylor; Alexey Seregin; Jeanon Smith; Bi-Hung Peng; Aida Walker; Jenna Linde; Jennifer Smith; Milagros Salazar; Slobodan Paessler
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

4.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

Review 5.  Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends.

Authors:  Goro Kuno; Gwong-Jen J Chang
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

6.  Reverse transcription-PCR-enzyme-linked immunosorbent assay for rapid detection and differentiation of alphavirus infections.

Authors:  Eryu Wang; Slobodan Paessler; Patricia V Aguilar; Anne-Sophie Carrara; Haolin Ni; Ivorlyne P Greene; Scott C Weaver
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

7.  Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins.

Authors:  Andrey A Kolokoltsov; Scott C Weaver; Robert A Davey
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 8.  Encephalitic alphaviruses.

Authors:  Michele A Zacks; Slobodan Paessler
Journal:  Vet Microbiol       Date:  2009-08-28       Impact factor: 3.293

9.  A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV).

Authors:  Donald L Fine; Erin Jenkins; Shannon S Martin; Pamela Glass; Michael D Parker; Brad Grimm
Journal:  J Virol Methods       Date:  2009-11-10       Impact factor: 2.014

10.  Ontology for vector surveillance and management.

Authors:  Saul Lozano-Fuentes; Aritra Bandyopadhyay; Lindsay G Cowell; Albert Goldfain; Lars Eisen
Journal:  J Med Entomol       Date:  2013-01       Impact factor: 2.278

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.